Kintor Pharmaceutical Limited

SEHK:9939 Stock Report

Market Cap: HK$458.9m

Kintor Pharmaceutical Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Youzhi Tong

Chief executive officer

CN¥6.9m

Total compensation

CEO salary percentagen/a
CEO tenure6.5yrs
CEO ownership10.7%
Management average tenureno data
Board average tenure4.1yrs

Recent management updates

Recent updates

Is Kintor Pharmaceutical (HKG:9939) Using Debt In A Risky Way?

Oct 07
Is Kintor Pharmaceutical (HKG:9939) Using Debt In A Risky Way?

Does Kintor Pharmaceutical (HKG:9939) Have A Healthy Balance Sheet?

Nov 16
Does Kintor Pharmaceutical (HKG:9939) Have A Healthy Balance Sheet?

Does Kintor Pharmaceutical (HKG:9939) Have A Healthy Balance Sheet?

Apr 28
Does Kintor Pharmaceutical (HKG:9939) Have A Healthy Balance Sheet?

Does Kintor Pharmaceutical (HKG:9939) Have A Healthy Balance Sheet?

Dec 06
Does Kintor Pharmaceutical (HKG:9939) Have A Healthy Balance Sheet?

Is Kintor Pharmaceutical (HKG:9939) Using Debt Sensibly?

Sep 01
Is Kintor Pharmaceutical (HKG:9939) Using Debt Sensibly?

Kintor Pharmaceutical Limited (HKG:9939) Insiders Increased Their Holdings

Feb 17
Kintor Pharmaceutical Limited (HKG:9939) Insiders Increased Their Holdings

What Kind Of Investors Own Most Of Kintor Pharmaceutical Limited (HKG:9939)?

Dec 23
What Kind Of Investors Own Most Of Kintor Pharmaceutical Limited (HKG:9939)?

CEO Compensation Analysis

How has Youzhi Tong's remuneration changed compared to Kintor Pharmaceutical's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-CN¥920m

Mar 31 2024n/an/a

-CN¥991m

Dec 31 2023CN¥7mn/a

-CN¥1b

Sep 30 2023n/an/a

-CN¥854m

Jun 30 2023n/an/a

-CN¥648m

Mar 31 2023n/an/a

-CN¥801m

Dec 31 2022CN¥7mCN¥6m

-CN¥954m

Sep 30 2022n/an/a

-CN¥995m

Jun 30 2022n/an/a

-CN¥1b

Mar 31 2022n/an/a

-CN¥938m

Dec 31 2021CN¥6mCN¥4m

-CN¥842m

Sep 30 2021n/an/a

-CN¥740m

Jun 30 2021n/an/a

-CN¥639m

Mar 31 2021n/an/a

-CN¥573m

Dec 31 2020CN¥3mCN¥2m

-CN¥508m

Sep 30 2020n/an/a

-CN¥419m

Jun 30 2020n/an/a

-CN¥330m

Mar 31 2020n/an/a

-CN¥281m

Dec 31 2019CN¥2mCN¥2m

-CN¥233m

Compensation vs Market: Youzhi's total compensation ($USD954.66K) is above average for companies of similar size in the Hong Kong market ($USD233.50K).

Compensation vs Earnings: Youzhi's compensation has been consistent with company performance over the past year.

CEO

Youzhi Tong (62 yo)

6.5yrs

Tenure

CN¥6,911,000

Compensation

Dr. Youzhi Tong serves as the Executive Chairman of the Board and Chief Executive Officer of Kintor Pharmaceutical Limited and has been its Executive Director since May 16, 2018. Dr. Tong is Founder of Kin...

Board Members

NamePositionTenureCompensationOwnership
Youzhi Tong
Founder6.5yrsCN¥6.91m10.68%
HK$ 49.0m
Xiang Ni
Chief Medical Officer & Executive Director1.6yrsCN¥4.66mno data
Wai Yim Yeung
Independent Non-Executive Director5.3yrsCN¥272.00kno data
Weipeng Gao
Non-Executive Director3.4yrsno datano data
Min Xu
Independent Non-Executive Director5.3yrsCN¥272.00kno data
Liang Tong
Independent Non-Executive Director4.1yrsCN¥272.00kno data
Geqi Wei
Non-Executive Director3.2yrsno datano data

4.1yrs

Average Tenure

59yo

Average Age

Experienced Board: 9939's board of directors are considered experienced (4.1 years average tenure).